T3 · Product exporter position

China exports of Pharmaceutical goods: opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient (HS 300630)

See where China stands in pharmaceutical goods: opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient: export scale, destination breadth, market position, growth, and reported trade history.

Explore this product View destinations

Exporter CHNHS6 300630Latest year 2024Rapid decline

Latest exports

$344.5MLatest observed lane total

Destination markets

110Reported active markets

Three-year growth

-12.6%Annualized change

Destination HHI

2,504Destination concentration

Weighted share

30.5%Reported market position

Exporter evidence

How strong is China in Pharmaceutical goods: opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient?

Reported exporter totals and calculated indicators for HS 300630. Values retain their observed coverage period.

Exporter scale

Latest exports$344.5M

Current 2024 exports$343.6M

Three-year average$321.8M

Historical peak$619.6M

Market position

Active destinations110

Destination HHI2,504

Weighted share30.5%

Share change+3.6 pp

Competitiveness

Three-year growth-12.6%

Volatility0.9

Maximum drawdown90.4%

TrendRapid decline

Measure	Value	What it describes
Exporter	China	Country represented by this profile
Latest observed exports	$344.5M	Sum of latest observed destination-lane values
Current 2024 exports	$343.6M	Common-year comparison where reported
Three-year growth	-12.6%	Annualized change in exporter totals
Five-year growth	-6.1%	Annualized change in exporter totals
Leading destination	USA	Destination with the largest observed export value
Leading destination share	45.4%	Share of observed exporter totals
Destination concentration	2,504	HHI across destination markets
Weighted share change	+3.6 pp	Value-weighted latest change in market share
Limited-history lanes	17.3%	Share of lanes with shorter history

Destination markets

Where does China sell pharmaceutical goods: opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient?

Leading destination observations ranked by reported export value, with market position and access context.

Destination	Latest exports	Market share	Growth	Access	Signal
USA, Puerto Rico and US Virgin Islands	$156.4M	14.4%	-16.5%	0% tariff	Accelerating
India	$48.3M	69.5%	-4.3%	0.5% tariff	Accelerating
Republic of Korea	$29.6M	25.9%	-3.2%	FTA reported	Growing
Australia	$29.3M	53.3%	-4.3%	FTA reported	Accelerating
Brazil	$27.9M	48.5%	-1.3%	0.3% tariff	Accelerating
Canada	$18.0M	28.4%	-16.3%	0.1% tariff	Accelerating

Destination

USA, Puerto Rico and US Virgin Islands

Latest exports: $156.4M
Market share: 14.4%
Growth: -16.5%
Access: 0% tariff
Signal: Accelerating

Destination

India

Latest exports: $48.3M
Market share: 69.5%
Growth: -4.3%
Access: 0.5% tariff
Signal: Accelerating

Destination

Republic of Korea

Latest exports: $29.6M
Market share: 25.9%
Growth: -3.2%
Access: FTA reported
Signal: Growing

Destination

Australia

Latest exports: $29.3M
Market share: 53.3%
Growth: -4.3%
Access: FTA reported
Signal: Accelerating

Destination

Brazil

Latest exports: $27.9M
Market share: 48.5%
Growth: -1.3%
Access: 0.3% tariff
Signal: Accelerating

Destination

Canada

Latest exports: $18.0M
Market share: 28.4%
Growth: -16.3%
Access: 0.1% tariff
Signal: Accelerating

Price intelligence

How does China's price position vary?

Price comparisons are shown where market-level unit-value observations are available. They describe reported trade values and quantities, not quoted selling prices.

Highest reported price

Saudi Arabia: $55.6M / ton.

Lowest reported price

Paraguay: $79.4 / ton.

Median price

$47.1K / ton across reported markets.

Export trend

Reported export history

Annual observations for China and HS 300630 where available.

Year	Exports	Year-on-year change	Active destinations
2010	$260.4M	+3.2%	127
2011	$262.2M	+0.7%	123
2012	$299.1M	+14.1%	137
2013	$370.8M	+24%	134
2014	$390.6M	+5.3%	103
2015	$446.2M	+14.2%	103
2016	$493.2M	+10.5%	96
2017	$466.8M	-5.4%	104
2018	$430.1M	-7.9%	120
2019	$470.7M	+9.4%	124
2020	$391.3M	-16.9%	128
2021	$514.4M	+31.5%	137
2022	$352.6M	-31.5%	133
2023	$269.2M	-23.7%	100
2024	$343.6M	+27.7%	110

Exporter context

China economy and trade network

The exporter profile adds country-level trade and structural context to the selected product position. These indicators describe the country overall and are not limited to HS 300630.

China has reported exports of $3.5T and a trade balance of $1.2T in 2024.

Available structural indicators include 34.6% trade openness, 44.5% investment, and 270 active trade partners.

Reported values

Export totals and destination values describe reported merchandise trade for the stated exporter, HS6 classification, and available year.

Calculated indicators

Growth, concentration, weighted share, volatility, drawdown, and price comparisons are calculated from reported observations.

Coverage

Missing values remain “Not reported”. Country-level indicators are presented separately from product-level observations.

Frequently asked questions

Questions about China pharmaceutical goods: opacifying preparations for x-ray examinations, diagnostic reagents designed to be administered to the patient exports

Quick answers based on the figures and coverage shown on this page.

How strong is this exporter?

Use latest exports, destination breadth, growth, concentration, and weighted share together rather than relying on one measure.

Which markets are most important?

The destination table ranks reported markets by the latest observed export value.

Does the price section show quotes?

No. It summarizes reported trade value and quantity observations converted to unit values.

What should be checked next?

Compare this exporter with buyer markets, corridors, and the product overview before making a commercial decision.